Surprising Surge of Egg Freezing During the Pandemic Raises Ethical Questions
By Danielle Pacia and Jacob Howard,
Bioethics Forum
| 01. 21. 2021
In the midst of the pandemic, life has been put on hold in a multitude of ways. Many women are taking a literal approach and electing to freeze their eggs with a process known as oocyte cryopreservation (OCP). Contrary to the expectations of many fertility clinics, OCP has increased sharply in 2020, reports Time. What was supposed to be a bust for the fertility industry has become a boom. As clinics grapple with this unexpected surge, pre-pandemic concerns about a lack of information on risks, benefits, and harms of OCP have persisted and are likely being exacerbated amidst the Covid-19 pandemic.
Prior to 2020, interest in egg freezing had already been increasing at a rapid rate. According to a study published in 2017 by the Society for Assisted Reproductive Technology, banking and freezing of eggs increased by 24% between 2016 and 2017. Each year, more women participate in the expensive process of OCP, with costs ranging from $6,000 to $20,000 per cycle, and additional yearly storage fees of $500 to $600. As popularity has risen, ethicists have voiced...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...